ICCC - ImmuCell Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 539.15M
Enterprise Value 339.72M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.75
Price/Book (mrq)1.72
Enterprise Value/Revenue 33.81
Enterprise Value/EBITDA 664.86

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin -1.61%
Operating Margin (ttm)-2.33%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)-0.83%

Income Statement

Revenue (ttm)10.43M
Revenue Per Share (ttm)2.11
Quarterly Revenue Growth (yoy)41.50%
Gross Profit (ttm)5.42M
EBITDA 612.29k
Net Income Avi to Common (ttm)-168k
Diluted EPS (ttm)-0.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.31M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)5.9M
Total Debt/Equity (mrq)28.18
Current Ratio (mrq)N/A
Book Value Per Share (mrq)4.15

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta 2.43
52-Week Change 328.62%
S&P500 52-Week Change 315.75%
52 Week High 39.25
52 Week Low 35.24
50-Day Moving Average 37.23
200-Day Moving Average 37.54

Share Statistics

Avg Vol (3 month) 311.61k
Avg Vol (10 day) 34.47k
Shares Outstanding 55.48M
Float 3.59M
% Held by Insiders 128.99%
% Held by Institutions 112.59%
Shares Short 310.69k
Short Ratio 30.83
Short % of Float 30.31%
Shares Short (prior month) 312.4k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/100
Last Split Date 3Jul 25, 1990